Menu

Adult Humans Can Regenerate Cartilage: Study

Collagen inside ankles has more turnover than that in hips, thanks to the action of microRNAs.

Oct 10, 2019
Shawna Williams

ABOVE: © ISTOCK.COM, KWANCHAICHAIUDOM

Humans, unlike some lucky members of the animal kingdom, have a very limited ability to regrow damaged or missing body parts. But a study published yesterday (October 9) in Science Advances finds that we can generate new proteins in joint cartilage, and this ability is more pronounced in joints farther from the center of the body, such as the ankles, than in those nearer in, such as the hips. The mechanism for this ability resembles that used by animals such as salamanders and axolotls to regrow lost limbs.

“We believe that an understanding of this ‘salamander-like’ regenerative capacity in humans, and the critically missing components of this regulatory circuit, could provide the foundation for new approaches to repair joint tissues and possibly whole human limbs,” says coauthor Virginia Kraus, who researches osteoarthritis at Duke University School of Medicine, in a university press release.

Kraus and her colleagues analyzed proteins from cartilage tissue from human hips, knees, and ankles for changes to amino acids that occur with time. “We suddenly started noticing that the ankle proteins tended by and large to be much younger than the same proteins in the knee and the same proteins in the hip,” Kraus tells The Guardian

The researchers found that the prevalence of younger proteins was tied to the abundance of a microRNA that blocks the action of a messenger RNA that inhibits the production of new collagen proteins. Similar microRNAs are active in animals that can regrow limbs, the authors note—and, as in humans, the animals’ regeneration ability is greater in distal parts of the body than in more central ones.

Writing to Gizmodo, Kraus says she is “very hopeful” that the findings could lead to therapies. Potentially, she suggests, microRNAs could be “injected directly into a joint to boost repair to prevent osteoarthritis after a joint injury or even slow or reverse osteoarthritis once it has developed.” 

“It is amazing to find that although we humans have separated from the axolotl 400 million years ago in evolution, there are many pathways that are commonly shared between human and axolotl,” writes Prayag Murawala, a postdoc at the Research Institute of Molecular Pathology in Vienna, Austria, in an email to Gizmodo. Murawala, who was not involved in the study, adds that “although we still have a long way to go to explain why humans cannot regenerate, this study provides compelling evidence that there are many similarities in human and salamander limbs.”

Shawna Williams is an associate editor at The Scientist. Email her at swilliams@the-scientist.com or follow her on Twitter @coloradan.

November 2019

Oceanic Connections

Biologists consider the movements of marine animals

Marketplace

Sponsored Product Updates

Diagenode to Offer Single-Cell ATAC-Seq Services Featuring Bio-Rad’s Droplet Digital PCR Technology
Diagenode to Offer Single-Cell ATAC-Seq Services Featuring Bio-Rad’s Droplet Digital PCR Technology
Diagenode, Inc., a leading global provider of solutions for epigenetics research and sample preparation, and Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital PCR technology, to help advance epigenomics research.
Bio-Rad Introduces EveryBlot Blocking Buffer that Offers 5-Minute Blocking Time and Greater Sensitivity for Western Blots
Bio-Rad Introduces EveryBlot Blocking Buffer that Offers 5-Minute Blocking Time and Greater Sensitivity for Western Blots
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of EveryBlot Blocking Buffer, a western blot blocking reagent that offers 5-minute blocking time and produces higher signal and lower background levels resulting in greater sensitivity for western blots compared to other available blocking buffers.
TTP plc Desktop Biology enables development and manufacture of DnaNudge technology
TTP plc Desktop Biology enables development and manufacture of DnaNudge technology
·        Novel multiplex technology developed to help consumers make healthier choices based on their genetic profile·        TTP involved with all aspects of product development, from initial concept to prototype testing and manufacture·        Culmination of technology and product development partnership spanning just over 3 years
Targos and Ultivue partner to incorporate highly standardized UltiMapper™ tissue multiplex phenotypic assays in support of clinical research services
Targos and Ultivue partner to incorporate highly standardized UltiMapper™ tissue multiplex phenotypic assays in support of clinical research services
Targos Molecular Pathology GmbH, a market leader in clinical biomarker services announced today a technology partnership with Ultivue, the innovation leader in multiplex tissue biomarker assays, to offer the biopharmaceutical industry new capabilities to improve the characterization of cancer patients’ samples selected for clinical research programs.